Grants Search Results

This institution is a member of a research consortium which is being funded by St. Baldrick's: Late Effects After High Risk Neuroblastoma – The LEAHRN Study. For a description of this project, see the consortium grant made to the lead institution: University of Chicago, Chicago, IL

This institution is a member of a research consortium which is being funded by St. Baldrick's: Late Effects After High Risk Neuroblastoma – The LEAHRN Study. For a description of this project, see the consortium grant made to the lead institution: University of Chicago, Chicago, IL

This institution is a member of a research consortium which is being funded by St. Baldrick's: Late Effects After High Risk Neuroblastoma – The LEAHRN Study. For a description of this project, see the consortium grant made to the lead institution: University of Chicago, Chicago, IL

This institution is a member of a research consortium which is being funded by St. Baldrick's: Late Effects After High Risk Neuroblastoma – The LEAHRN Study. For a description of this project, see the consortium grant made to the lead institution: University of Chicago, Chicago, IL

This institution is a member of a research consortium which is being funded by St. Baldrick's: Late Effects After High Risk Neuroblastoma – The LEAHRN Study. For a description of this project, see the consortium grant made to the lead institution: University of Chicago, Chicago, IL

This institution is a member of a research consortium which is being funded by St. Baldrick's: Late Effects After High Risk Neuroblastoma – The LEAHRN Study. For a description of this project, see the consortium grant made to the lead institution: University of Chicago, Chicago, IL

By increasing physical activity, survivors may reduce their risk of obesity and chronic diseases, and improve their quality of life. Dr. Mendoza's research aims to examine the use of a wearable physical activity device, the Fitbit, paired with a Facebook group, to increase physical activity among teen childhood cancer survivors. This approach aims to harness new wearable technology and the widespread use of smart phones to use individual- and peer-influences to promote physical activity.

Survivors of pediatric brain tumors commonly struggle with progressive declines in attention and memory that emerge following neurosurgery, chemotherapy and radiation. Unfortunately, little is known about the neurobiological substrates of these cognitive dysfunctions. Dr. Posner's Grace for Good St. Baldrick’s Supportive Care Grant aims to identify the specific changes in functional and structural brain connectivity that correlate with neurocognitive decline by collecting advanced magnetic resonance imaging (MRI) and neuropsychological test data on survivors. This data is being compared with healthy controls across three academic medical centers: Columbia University Medical Center, Children’s Medical Center-Dallas and Seattle Children’s Hospital. This grant is named for the Grace for Good Fund created in honor of Grace Carey, a medulloblastoma survivor. It supports research of brain tumors and survivorship issues in the hopes of changing kids’ lives for good.

Adolescents and young adults with cancer do not receive adequate support and face a higher rate of relapse relative to younger patients. Dr. Schwartz's project is taking a current texting intervention which aims to improve health-related knowledge and engagement, and upgrading the technology and content in order to maximize the impact. This research aims to ultimately help improve the health and well-being of adolescents and young adults with cancer.

Most childhood cancer survivors develop complications associated with their treatment and many will require hospitalization. Dr. Smitherman is working to determine how often survivors are seen in an emergency department or hospitalized in the first years following completion of treatment. This research is also reviewing which medications are prescribed during this time to better understand what medical complications survivors are experiencing. With this knowledge, Dr. Smitherman hopes to prevent complications and improve survivors' quality of life.

This grant helps provide necessary resources for the Long Term Follow-up Program at this institution, enhancing research while providing childhood cancer survivors the support, treatment and education they need to prevent and address late effects.

This grant helps provide necessary resources for the Survivors’ Treatment Assessment and Resource (STAR) program at this institution, enhancing research while providing childhood cancer survivors the support, treatment and education they need to prevent and address late effects.

This grant helps provide necessary resources to support the Survivorship Clinic, and to study, through increased clinical trial enrollment, the late effects of recently treated children.

This grant helps provide necessary resources for the Childhood Cancer Survivorship Program at this institution, enhancing research while providing childhood cancer survivors the support, treatment and education they need to prevent and address late effects.

Based on progress to date, Dr. Aune was awarded new grants in 2017 and 2018 to fund additional years of this Scholar award. Survival from pediatric cancer approaches 80%, but long-term survivors have alarming rates of heart disease as adults. Dr. Aune's lab has developed models to study how pediatric cancer therapies affect the heart. This research aims to determine the potential for new chemotherapy agents to damage the heart. These strategies will lead to a better quality of life for children who survive cancer.

Although most kids with a brain tumor survive the tumor itself, many have trouble doing activities that require attention and memory, and they often have difficulty fitting in with peers. Both types of difficulty could be related to changes in their brain structure or function, but research on this hasn'’t been done yet. Dr. Hoskinson is looking at whether there's a connection between these changes in brain structure and function and how kids get along with their peers. If there is, this research aims to help predict which kids will have social problems after treatment and identify ways to help.

Most children treated for cancer can now expect to be cured. However, in a significant majority, future fertility may be compromised by their disease or its treatment. Girls are particularly at risk to ovarian injury. These children are cured; however the girls will live the rest of their life in menopause and they will also sadly be unable to have a child of their own. Dr. Lukish's work aims to open the field of ovarian cryopreservation in children by providing an evidence base for future practice, with significant potential benefit to young girls with cancer.

This grant funds a Clinical Research Associate to further develop and enhance the survivor program and develop effective outreach to this population.

This grant helps provide necessary resources to support the Survivorship Clinic, and to study, through increased clinical trial enrollment, the late effects of recently treated children.

This grant provides resources to help build an AYA Survivorship Program, to ensure that more adolescents and young adults can be treated on clinical trials, and to provide survivorship planning.